Cheng‐Bo Han

Meta-analysis of the impact of de novo and acquired <em>EGFR</em> T790M mutations on the prognosis of patients with non-small cell lung cancer receiving EGFR-TKIs

Yang Liu, Li Sun, Zhicheng Xiong et al. · OncoTargets and Therapy · 2017 · 52 citations · Full text

Circlular RNA BARD1 (Hsa_circ_0001098) overexpression in breast cancer cells with TCDD treatment could promote cell apoptosis via miR-3942/BARD1 axis

Jianzhu Zhao, Huawei Zou, Cheng‐Bo Han et al. · Cell Cycle · 2018 · 48 citations · Full text

Cell Death, Cancer Biology, Tumor Biology +16

Doses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancer

Jianxin Xue, Cheng‐Bo Han, Andrew Jackson et al. · Radiotherapy and Oncology · 2018 · 44 citations

Radiation Therapy, Medicine, Bronchial Neoplasm +8

Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?

Jie‐Tao Ma, Li Sun, Xin Sun et al. · Radiation Oncology · 2017 · 42 citations · Full text

Real‐world <i>EGFR</i> testing in patients with stage IIIB/IV non‐small‐cell lung cancer in North China: A multicenter, non‐interventional study

Ying Cheng, Yan Wang, Jun Zhao et al. · Thoracic Cancer · 2018 · 36 citations · Full text